FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Sci Rep / Safe and effective aerosolization of in vitro transcribed mR...
Scientific reports2021; 11(1); 371; doi: 10.1038/s41598-020-79855-1

Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent.

Abstract: Vaccines and therapeutics using in vitro transcribed mRNA hold enormous potential for human and veterinary medicine. Transfection agents are widely considered to be necessary to protect mRNA and enhance transfection, but they add expense and raise concerns regarding quality control and safety. We found that such complex mRNA delivery systems can be avoided when transfecting epithelial cells by aerosolizing the mRNA into micron-sized droplets. In an equine in vivo model, we demonstrated that the translation of mRNA into a functional protein did not depend on the addition of a polyethylenimine (PEI)-derived transfection agent. We were able to safely and effectively transfect the bronchial epithelium of foals using naked mRNA (i.e., mRNA formulated in a sodium citrate buffer without a delivery vehicle). Endoscopic examination of the bronchial tree and histology of mucosal biopsies indicated no gross or microscopic adverse effects of the transfection. Our data suggest that mRNA administered by an atomization device eliminates the need for chemical transfection agents, which can reduce the cost and the safety risks of delivering mRNA to the respiratory tract of animals and humans.
Get Full Text
Publication Date: 2021-01-11 PubMed ID: 33432084PubMed Central: PMC7801524DOI: 10.1038/s41598-020-79855-1Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article discusses the potential of using in vitro transcribed mRNA to make vaccines and therapeutics more effectively and safely by aerosolizing the mRNA into micron-sized droplets, eliminating the need for transfection agents in the process. This technique was successfully tested on the respiratory tract epithelium of horses.

Introduction to the Research

  • The research focuses on exploring the potential of using in vitro transcribed mRNA in veterinary and human medicine. mRNA is used to produce vaccines and therapeutics. The study sought to find a safe and effective way of delivering this mRNA to the cells.
  • Traditionally, transfection agents are used for this purpose. These are substances that help protect the mRNA and enhance its ability to enter the cells (transfection). However, these transfection agents come with their own drawbacks – they add expense and they raise concerns regarding quality control and safety.

The Study and its Findings

  • The researchers did away with complex mRNA delivery systems by aerosolizing the mRNA into micron-sized droplets to transfect epithelial cells.
  • They then tested this method on an in vivo model by using horses, specifically focusing on the bronchial epithelium in foals. They found that the translation of mRNA into a functional protein did not depend on the addition of a polyethylenimine (PEI)-derived transfection agent. This shows that the mRNA can function without the need for these agents.
  • Such mRNA is termed ‘naked’ mRNA since it is formulated in a sodium citrate buffer without a delivery vehicle or transfection agent.
  • The researchers found no adverse effects from the mRNA transfection, both on the surface examination of the bronchial tree and upon histological examination of mucosal biopsies. This demonstrates that their method can be considered safe.

Implications of the Research

  • By eliminating the need for chemical transfection agents, this new method of administering mRNA by an atomization device can reduce the cost and safety risks associated with using mRNA in the respiratory tract of animals and humans.
  • This method will potentially make the creation and delivery of mRNA based vaccines and therapeutics safer, simpler, and more cost-effective.

Cite This Article

APA
Legere RM, Cohen ND, Poveda C, Bray JM, Barhoumi R, Szule JA, de la Concha-Bermejillo A, Bordin AI, Pollet J. (2021). Safe and effective aerosolization of in vitro transcribed mRNA to the respiratory tract epithelium of horses without a transfection agent. Sci Rep, 11(1), 371. https://doi.org/10.1038/s41598-020-79855-1

Publication

Scientific reports
ISSN: 2045-2322
NlmUniqueID: 101563288
Country: England
Language: English
Volume: 11
Issue: 1
Pages: 371
PII: 371

Researcher Affiliations

Legere, Rebecca M
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Cohen, Noah D
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA. ncohen@cvm.tamu.edu.
Poveda, Cristina
  • Department of Pediatrics, National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Bray, Jocelyne M
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Barhoumi, Rola
  • Department of Veterinary Integrative Biosciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Szule, Joseph A
  • Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
de la Concha-Bermejillo, Andrés
  • Texas A&M Veterinary Medical Diagnostic Laboratory, Texas A&M University, College Station, TX, USA.
Bordin, Angela I
  • Department of Large Animal Clinical Sciences, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
Pollet, Jeroen
  • Department of Pediatrics, National School of Tropical Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. Jeroen.pollet@bcm.edu.
  • Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, 1102 Bates Street, Houston, TX, USA. Jeroen.pollet@bcm.edu.

MeSH Terms

  • Animals
  • Animals, Newborn
  • Cells, Cultured
  • Drug Carriers / administration & dosage
  • Drug Carriers / adverse effects
  • Drug Carriers / pharmacokinetics
  • Drug Delivery Systems / adverse effects
  • Drug Delivery Systems / methods
  • Drug Delivery Systems / veterinary
  • Epithelial Cells / drug effects
  • Epithelial Cells / metabolism
  • Female
  • Horses
  • Lung / drug effects
  • Lung / metabolism
  • Nasal Sprays
  • Nebulizers and Vaporizers / veterinary
  • Polyethyleneimine / administration & dosage
  • Polyethyleneimine / chemistry
  • RNA, Messenger / administration & dosage
  • RNA, Messenger / adverse effects
  • RNA, Messenger / pharmacokinetics
  • Respiratory Mucosa / drug effects
  • Respiratory Mucosa / metabolism
  • Transcription, Genetic
  • Transfection / methods
  • Transfection / veterinary
  • Vaccines, DNA / administration & dosage
  • Vaccines, DNA / adverse effects
  • Vaccines, DNA / pharmacokinetics

Conflict of Interest Statement

The authors declare no competing interests.

References

This article includes 43 references
  1. Mulligan MJ. Phase 1/2 study to describe the safety and immunogenicity of a COVID-19 RNA vaccine candidate (BNT162b1) in adults 18 to 55 years of age: Interim report. MedRxiv 2020.
  2. Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, McCullough MP, Chappell JD, Denison MR, Stevens LJ, Pruijssers AJ, McDermott A, Flach B, Doria-Rose NA, Corbett KS, Morabito KM, O'Dell S, Schmidt SD, Swanson PA 2nd, Padilla M, Mascola JR, Neuzil KM, Bennett H, Sun W, Peters E, Makowski M, Albert J, Cross K, Buchanan W, Pikaart-Tautges R, Ledgerwood JE, Graham BS, Beigel JH. An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.. N Engl J Med 2020 Nov 12;383(20):1920-1931.
    pmc: PMC7377258pubmed: 32663912doi: 10.1056/nejmoa2022483google scholar: lookup
  3. Pardi N, Hogan MJ, Porter FW, Weissman D. mRNA vaccines - a new era in vaccinology.. Nat Rev Drug Discov 2018 Apr;17(4):261-279.
    doi: 10.1038/nrd.2017.243pmc: PMC5906799pubmed: 29326426google scholar: lookup
  4. Kowalski PS, Rudra A, Miao L, Anderson DG. Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.. Mol Ther 2019 Apr 10;27(4):710-728.
    doi: 10.1016/j.ymthe.2019.02.012pmc: PMC6453548pubmed: 30846391google scholar: lookup
  5. Patel A, Bah MA, Weiner DB. In Vivo Delivery of Nucleic Acid-Encoded Monoclonal Antibodies.. BioDrugs 2020 Jun;34(3):273-293.
    doi: 10.1007/s40259-020-00412-3pmc: PMC7211204pubmed: 32157600google scholar: lookup
  6. Berraondo P, Martini PGV, Avila MA, Fontanellas A. Messenger RNA therapy for rare genetic metabolic diseases.. Gut 2019 Jul;68(7):1323-1330.
    doi: 10.1136/gutjnl-2019-318269pubmed: 30796097google scholar: lookup
  7. Gan LM, Lagerström-Fermér M, Carlsson LG, Arfvidsson C, Egnell AC, Rudvik A, Kjaer M, Collén A, Thompson JD, Joyal J, Chialda L, Koernicke T, Fuhr R, Chien KR, Fritsche-Danielson R. Intradermal delivery of modified mRNA encoding VEGF-A in patients with type 2 diabetes.. Nat Commun 2019 Feb 20;10(1):871.
    doi: 10.1038/s41467-019-08852-4pmc: PMC6382754pubmed: 30787295google scholar: lookup
  8. Vallazza B, Petri S, Poleganov MA, Eberle F, Kuhn AN, Sahin U. Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond.. Wiley Interdiscip Rev RNA 2015 Sep-Oct;6(5):471-99.
    doi: 10.1002/wrna.1288pubmed: 26061157google scholar: lookup
  9. Van Hoecke L, Verbeke R, De Vlieger D, Dewitte H, Roose K, Van Nevel S, Krysko O, Bachert C, Schepens B, Lentacker I, Saelens X. mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice.. Mol Ther Nucleic Acids 2020 Jun 5;20:777-787.
    doi: 10.1016/j.omtn.2020.04.015pmc: PMC7240188pubmed: 32438313google scholar: lookup
  10. Tiwari PM, Vanover D, Lindsay KE, Bawage SS, Kirschman JL, Bhosle S, Lifland AW, Zurla C, Santangelo PJ. Engineered mRNA-expressed antibodies prevent respiratory syncytial virus infection.. Nat Commun 2018 Oct 1;9(1):3999.
    doi: 10.1038/s41467-018-06508-3pmc: PMC6167369pubmed: 30275522google scholar: lookup
  11. Lindsay KE, Vanover D, Thoresen M, King H, Xiao P, Badial P, Araínga M, Park SB, Tiwari PM, Peck HE, Blanchard EL, Feugang JM, Olivier AK, Zurla C, Villinger F, Woolums AR, Santangelo PJ. Aerosol Delivery of Synthetic mRNA to Vaginal Mucosa Leads to Durable Expression of Broadly Neutralizing Antibodies against HIV.. Mol Ther 2020 Mar 4;28(3):805-819.
    doi: 10.1016/j.ymthe.2020.01.002pmc: PMC7054722pubmed: 31995741google scholar: lookup
  12. Erasmus JH, Archer J, Fuerte-Stone J, Khandhar AP, Voigt E, Granger B, Bombardi RG, Govero J, Tan Q, Durnell LA, Coler RN, Diamond MS, Crowe JE Jr, Reed SG, Thackray LB, Carnahan RH, Van Hoeven N. Intramuscular Delivery of Replicon RNA Encoding ZIKV-117 Human Monoclonal Antibody Protects against Zika Virus Infection.. Mol Ther Methods Clin Dev 2020 Sep 11;18:402-414.
    doi: 10.1016/j.omtm.2020.06.011pmc: PMC7363633pubmed: 32695842google scholar: lookup
  13. Wolff JA, Malone RW, Williams P, Chong W, Acsadi G, Jani A, Felgner PL. Direct gene transfer into mouse muscle in vivo.. Science 1990 Mar 23;247(4949 Pt 1):1465-8.
    doi: 10.1126/science.1690918pubmed: 1690918google scholar: lookup
  14. Jirikowski GF, Sanna PP, Maciejewski-Lenoir D, Bloom FE. Reversal of diabetes insipidus in Brattleboro rats: intrahypothalamic injection of vasopressin mRNA.. Science 1992 Feb 21;255(5047):996-8.
    doi: 10.1126/science.1546298pubmed: 1546298google scholar: lookup
  15. Steenhuysen, J. Moderna COVID-19 vaccine appears to clear safety hurdle in mouse study. Reuters, June 12, 2020. https://www.reuters.com/article/us-health-coronavirus-moderna/moderna-covid-19-vaccine-appears-to-clear-safety-hurdle-in-mouse-study-idUSKBN23J2S4. Accessed 29 Jun 2020.
  16. Nelson J, Sorensen EW, Mintri S, Rabideau AE, Zheng W, Besin G, Khatwani N, Su SV, Miracco EJ, Issa WJ, Hoge S, Stanton MG, Joyal JL. Impact of mRNA chemistry and manufacturing process on innate immune activation.. Sci Adv 2020 Jun;6(26):eaaz6893.
    pmc: PMC7314518pubmed: 32637598doi: 10.1126/sciadv.aaz6893google scholar: lookup
  17. Wadhwa A, Aljabbari A, Lokras A, Foged C, Thakur A. Opportunities and Challenges in the Delivery of mRNA-based Vaccines.. Pharmaceutics 2020 Jan 28;12(2).
    doi: 10.3390/pharmaceutics12020102pmc: PMC7076378pubmed: 32013049google scholar: lookup
  18. Zeng C, Zhang C, Walker PG, Dong Y. Formulation and Delivery Technologies for mRNA Vaccines.. Curr Top Microbiol Immunol 2022;440:71-110.
    pubmed: 32483657doi: 10.1007/82_2020_217google scholar: lookup
  19. Patel S, Ashwanikumar N, Robinson E, DuRoss A, Sun C, Murphy-Benenato KE, Mihai C, Almarsson Ö, Sahay G. Boosting Intracellular Delivery of Lipid Nanoparticle-Encapsulated mRNA.. Nano Lett 2017 Sep 13;17(9):5711-5718.
    doi: 10.1021/acs.nanolett.7b02664pmc: PMC5623340pubmed: 28836442google scholar: lookup
  20. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems.. Annu Rev Biomed Eng 2012;14:1-16.
    doi: 10.1146/annurev-bioeng-071811-150124pubmed: 22524388google scholar: lookup
  21. Jahanafrooz Z, Baradaran B, Mosafer J, Hashemzaei M, Rezaei T, Mokhtarzadeh A, Hamblin MR. Comparison of DNA and mRNA vaccines against cancer.. Drug Discov Today 2020 Mar;25(3):552-560.
    doi: 10.1016/j.drudis.2019.12.003pmc: PMC7080609pubmed: 31843577google scholar: lookup
  22. Kormann MS, Hasenpusch G, Aneja MK, Nica G, Flemmer AW, Herber-Jonat S, Huppmann M, Mays LE, Illenyi M, Schams A, Griese M, Bittmann I, Handgretinger R, Hartl D, Rosenecker J, Rudolph C. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice.. Nat Biotechnol 2011 Feb;29(2):154-7.
    doi: 10.1038/nbt.1733pubmed: 21217696google scholar: lookup
  23. Patel AK, Kaczmarek JC, Bose S, Kauffman KJ, Mir F, Heartlein MW, DeRosa F, Langer R, Anderson DG. Inhaled Nanoformulated mRNA Polyplexes for Protein Production in Lung Epithelium.. Adv Mater 2019 Feb;31(8):e1805116.
    doi: 10.1002/adma.201805116pmc: PMC7490222pubmed: 30609147google scholar: lookup
  24. Johler SM, Rejman J, Guan S, Rosenecker J. Nebulisation of IVT mRNA Complexes for Intrapulmonary Administration.. PLoS One 2015;10(9):e0137504.
    doi: 10.1371/journal.pone.0137504pmc: PMC4564175pubmed: 26352268google scholar: lookup
  25. Panzner S. Transfection: Viral and synthetic techniques converge. Genet. Eng. Biotechnol. News 2015;34:20–21.
    doi: 10.1089/gen.34.04.12google scholar: lookup
  26. Singh B, Maharjan S, Park TE, Jiang T, Kang SK, Choi YJ, Cho CS. Tuning the buffering capacity of polyethylenimine with glycerol molecules for efficient gene delivery: staying in or out of the endosomes.. Macromol Biosci 2015 May;15(5):622-35.
    doi: 10.1002/mabi.201400463pubmed: 25581293google scholar: lookup
  27. Kranz LM, Diken M, Haas H, Kreiter S, Loquai C, Reuter KC, Meng M, Fritz D, Vascotto F, Hefesha H, Grunwitz C, Vormehr M, Hüsemann Y, Selmi A, Kuhn AN, Buck J, Derhovanessian E, Rae R, Attig S, Diekmann J, Jabulowsky RA, Heesch S, Hassel J, Langguth P, Grabbe S, Huber C, Türeci Ö, Sahin U. Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy.. Nature 2016 Jun 16;534(7607):396-401.
    doi: 10.1038/nature18300pubmed: 27281205google scholar: lookup
  28. Jansig E, Geissler S, Rieckmann V, Kuenemund A, Hietel B, Schenk M, Wussow S, Kreideweiss P, Panzner S, Reinsch C, Cynis H. Viromers as carriers for mRNA-mediated expression of therapeutic molecules under inflammatory conditions.. Sci Rep 2020 Sep 15;10(1):15090.
    doi: 10.1038/s41598-020-72004-8pmc: PMC7494895pubmed: 32934311google scholar: lookup
  29. Kaufmann SH, Lange C, Rao M, Balaji KN, Lotze M, Schito M, Zumla AI, Maeurer M. Progress in tuberculosis vaccine development and host-directed therapies--a state of the art review.. Lancet Respir Med 2014 Apr;2(4):301-20.
    doi: 10.1016/S2213-2600(14)70033-5pubmed: 24717627google scholar: lookup
  30. de Groot PM, Wu CC, Carter BW, Munden RF. The epidemiology of lung cancer.. Transl Lung Cancer Res 2018 Jun;7(3):220-233.
    doi: 10.21037/tlcr.2018.05.06pmc: PMC6037963pubmed: 30050761google scholar: lookup
  31. Elborn JS. Cystic fibrosis.. Lancet 2016 Nov 19;388(10059):2519-2531.
    doi: 10.1016/S0140-6736(16)00576-6pubmed: 27140670google scholar: lookup
  32. Nickbakhsh S, Ho A, Marques DFP, McMenamin J, Gunson RN, Murcia PR. Epidemiology of Seasonal Coronaviruses: Establishing the Context for the Emergence of Coronavirus Disease 2019.. J Infect Dis 2020 Jun 16;222(1):17-25.
    doi: 10.1093/infdis/jiaa185pmc: PMC7184404pubmed: 32296837google scholar: lookup
  33. Anderson BR, Muramatsu H, Nallagatla SR, Bevilacqua PC, Sansing LH, Weissman D, Karikó K. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation.. Nucleic Acids Res 2010 Sep;38(17):5884-92.
    doi: 10.1093/nar/gkq347pmc: PMC2943593pubmed: 20457754google scholar: lookup
  34. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets.. Cell 2009 Feb 20;136(4):731-45.
    doi: 10.1016/j.cell.2009.01.042pmc: PMC3610329pubmed: 19239892google scholar: lookup
  35. Fabre AL, Colotte M, Luis A, Tuffet S, Bonnet J. An efficient method for long-term room temperature storage of RNA.. Eur J Hum Genet 2014 Mar;22(3):379-85.
    doi: 10.1038/ejhg.2013.145pmc: PMC3925273pubmed: 23860045google scholar: lookup
  36. Labiris NR, Dolovich MB. Pulmonary drug delivery. Part I: physiological factors affecting therapeutic effectiveness of aerosolized medications.. Br J Clin Pharmacol 2003 Dec;56(6):588-99.
    pmc: PMC1884307pubmed: 14616418doi: 10.1046/j.1365-2125.2003.01892.xgoogle scholar: lookup
  37. Sun S, Yang Y, Chen M, Wang L, Pan H, Zhang X, Wagnieres G, Mohammad Y, Barreiro E, Pirozzolo G, Villeneuve PJ, Zhan P, Wan B. Comparison of autofluorescence and white-light bronchoscopies performed with the Evis Lucera Spectrum for the detection of bronchial cancers: a meta-analysis.. Transl Lung Cancer Res 2020 Feb;9(1):23-32.
    doi: 10.21037/tlcr.2020.01.04pmc: PMC7082289pubmed: 32206550google scholar: lookup
  38. Thiberville L, Moreno-Swirc S, Vercauteren T, Peltier E, Cavé C, Bourg Heckly G. In vivo imaging of the bronchial wall microstructure using fibered confocal fluorescence microscopy.. Am J Respir Crit Care Med 2007 Jan 1;175(1):22-31.
    doi: 10.1164/rccm.200605-684OCpubmed: 17023733google scholar: lookup
  39. Dothager RS, Piwnica-Worms D. Molecular imaging of pulmonary disease in vivo.. Proc Am Thorac Soc 2009 Aug 15;6(5):403-10.
    doi: 10.1513/pats.200901-004AWpmc: PMC3266013pubmed: 19687211google scholar: lookup
  40. Davis AS, Richter A, Becker S, Moyer JE, Sandouk A, Skinner J, Taubenberger JK. Characterizing and Diminishing Autofluorescence in Formalin-fixed Paraffin-embedded Human Respiratory Tissue.. J Histochem Cytochem 2014 Jun;62(6):405-423.
    doi: 10.1369/0022155414531549pmc: PMC4174629pubmed: 24722432google scholar: lookup
  41. Shibeshi W, Abraham G, Kneuer C, Ellenberger C, Seeger J, Schoon HA, Ungemach FR. Isolation and culture of primary equine tracheal epithelial cells.. In Vitro Cell Dev Biol Anim 2008 Jul-Aug;44(7):179-84.
    doi: 10.1007/s11626-008-9099-8pubmed: 18594938google scholar: lookup
  42. Abraham G, Zizzadoro C, Kacza J, Ellenberger C, Abs V, Franke J, Schoon HA, Seeger J, Tesfaigzi Y, Ungemach FR. Growth and differentiation of primary and passaged equine bronchial epithelial cells under conventional and air-liquid-interface culture conditions.. BMC Vet Res 2011 Jun 7;7:26.
    doi: 10.1186/1746-6148-7-26pmc: PMC3117700pubmed: 21649893google scholar: lookup
  43. Frellstedt L, Gosset P, Kervoaze G, Hans A, Desmet C, Pirottin D, Bureau F, Lekeux P, Art T. The innate immune response of equine bronchial epithelial cells is altered by training.. Vet Res 2015 Jan 17;46(1):3.
    doi: 10.1186/s13567-014-0126-3pmc: PMC4297379pubmed: 25595212google scholar: lookup

Citations

This article has been cited 3 times.
  1. McCarthy SD, Rohde CB, Angel M, Masterson CH, MacLoughlin R, Fandiño J, González HE, Byrnes D, Laffey JG, O'Toole D. Aerosolized Pulmonary Delivery of mRNA Constructs Attenuates Severity of Escherichia coli Pneumonia in the Rat.. Nucleic Acid Ther 2023 Apr;33(2):148-158.
    doi: 10.1089/nat.2022.0049pubmed: 36811461google scholar: lookup
  2. Szabó GT, Mahiny AJ, Vlatkovic I. COVID-19 mRNA vaccines: Platforms and current developments.. Mol Ther 2022 May 4;30(5):1850-1868.
    doi: 10.1016/j.ymthe.2022.02.016pubmed: 35189345google scholar: lookup
  3. Chabanovska O, Galow AM, David R, Lemcke H. mRNA - A game changer in regenerative medicine, cell-based therapy and reprogramming strategies.. Adv Drug Deliv Rev 2021 Dec;179:114002.
    doi: 10.1016/j.addr.2021.114002pubmed: 34653534google scholar: lookup
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.